U.S. Renal Care Presents Eight Kidney Research Studies at ASN
PLANO, Texas, October 29, 2026 U.S. Renal Care (USRC) has announced the presentation of eight clinical research studies at...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
PLANO, Texas, October 29, 2026 U.S. Renal Care (USRC) has announced the presentation of eight clinical research studies at...
BERKELEY HEIGHTS, New Jersey | January 9, 2026 — CorMedix Therapeutics, a biopharmaceutical company focused on life-threatening infectious diseases,...
